Sinoway Industrial Co., Ltd.

Dabigatran Etexilate 211915-06-9 Dabigatran Etexilate 211915-06-9

Dabigatran Etexilate 211915-06-9
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of  Dabigatran etexilate :

Name

Dabigatran etexilate

Alias

BIBR-1048(Dabigatran etexilate);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-N-(2-;BIBR 1048;BIBR-1048;Prazaxa;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;Pradaxa (dabigatran);Dabigatran Etexilate (free base)

CAS NO.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.74

Brief Introduction

Dabigatran etexilate is a novel oral anticoagulant drug that exerts anticoagulant activity by directly inhibiting thrombin.


Use of  Dabigatran etexilate:

Dabigatran Etexilate is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases, it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for the international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.

  • Celecoxib 169590-42-5
    Basic information of Celecoxib:NameCelecoxibCAS NO.169590-42-5Molecular FormulaC17H14F3N3O2SMolecular Weight381.38Grade StandardMedicine grade / 99% min / USP/ EP / GMP application / PMDA / DMFPackag... Celecoxib 169590-42-5
  • Olmesartan Medoxomil 144689-63-4/144689-78-1
    Basic information of Olmesartan Medoxomil:NameOlmesartan MedoxomilMolecular FormulaC24H26N6O3Molecular Weight446.5Quality StandardI.H.SPackage Size25kg/drumBrief IntroductionOlmesartan medoxomil is an... Olmesartan Medoxomil 144689-63-4/144689-78-1
  • Oxaliplatin 61825-94-3
    Basic information of Oxaliplatin :Name OxaliplatinAliastrans-l-diaminocyclohexane oxalatoplatinum; oxalato(1r,2r-cyclohexanediammine)platinum(ii); oxalatoplatin; oxalatoplatinumCAS NO.61825-94-3Molecu... Oxaliplatin 61825-94-3
  • Iron Sucrose 8047-67-4
    Basic informationOther Names: Iron(III) saccharateCAS No.: 8047-67-4 Appearance:Brown-dark liquid Document: GMP/DMF/Technical support.Appearance:Brown-dark liquid UsageAnti-anemia medicine, which ca... Iron Sucrose 8047-67-4

MORE_DETAIL Dabigatran Etexilate 211915-06-9

Basic information of  Dabigatran etexilate :

Name

Dabigatran etexilate

Alias

BIBR-1048(Dabigatran etexilate);N-[2-[4-[N-(Hexyloxycarbonyl)aMidino]phenylaMinoMethyl]-1-Methyl-1H-benziMidazol-5-ylcarbonyl]-N-(2-;BIBR 1048;BIBR-1048;Prazaxa;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;Pradaxa (dabigatran);Dabigatran Etexilate (free base)

CAS NO.

211915-06-9

Molecular Formula

C34H41N7O5

Molecular Weight

627.74

Brief Introduction

Dabigatran etexilate is a novel oral anticoagulant drug that exerts anticoagulant activity by directly inhibiting thrombin.


Use of  Dabigatran etexilate:

Dabigatran Etexilate is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases, it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for the international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//